Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Tax Provisions (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Tax Provisions for 9 consecutive years, with $527.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Tax Provisions rose 48.45% year-over-year to $527.0, compared with a TTM value of $882.0 through Dec 2025, up 101.73%, and an annual FY2025 reading of $24154.0, up 121.85% over the prior year.
  • Tax Provisions was $527.0 for Q3 2025 at Abvc Biopharma, up from $355.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.0 million in Q4 2021 and bottomed at -$110894.0 in Q2 2024.
  • Average Tax Provisions over 5 years is $118080.6, with a median of -$322.0 recorded in 2023.
  • The sharpest move saw Tax Provisions soared 1270.39% in 2021, then tumbled 235.74% in 2024.
  • Year by year, Tax Provisions stood at $1.0 million in 2021, then dropped by 4.79% to $962874.0 in 2022, then tumbled by 93.81% to $59642.0 in 2023, then crashed by 99.4% to $355.0 in 2024, then soared by 48.45% to $527.0 in 2025.
  • Business Quant data shows Tax Provisions for ABVC at $527.0 in Q3 2025, $355.0 in Q3 2024, and -$110894.0 in Q2 2024.